Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR · Real-Time Price · USD
40.47
+0.32 (0.80%)
Nov 18, 2025, 4:00 PM EST - Market closed
Arrowhead Pharmaceuticals Analyst Ratings
Total Analysts
9
Consensus Rating
Buy
Price Target
$47.44
Upside
+17.22%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Maintains $29 → $45 | Hold | Maintains | $29 → $45 | +11.19% | Nov 12, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +97.68% | Oct 8, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +97.68% | Sep 2, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $60 | Strong Buy | Maintains | $60 | +48.26% | Aug 11, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $40 → $38 | Buy | Maintains | $40 → $38 | -6.10% | Aug 8, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +97.68% | May 20, 2025 |
| Citigroup | Citigroup | Hold Maintains $21 → $17 | Hold | Maintains | $21 → $17 | -57.99% | May 13, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $60 | Strong Buy | Maintains | $60 | +48.26% | May 13, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $51 → $38 | Strong Buy | Reiterates | $51 → $38 | -6.10% | Feb 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +97.68% | Feb 12, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $42 | Buy | Reiterates | $42 | +3.78% | Feb 11, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $60 | Strong Buy | Maintains | $60 | +48.26% | Feb 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +97.68% | Jan 23, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +97.68% | Dec 20, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $60 | Strong Buy | Maintains | $60 | +48.26% | Dec 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $60 → $80 | Strong Buy | Maintains | $60 → $80 | +97.68% | Dec 3, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.